TARGETED THERAPY IDENTIFIES AND ATTACKS CANCER CELLS PRECISELY
Targeted drugs find specific cancer cell markers such as HER2 or EGFR. This allows more accurate treatment while protecting healthy cells.
WHY COMBINATION THERAPY WORKS BETTER
Using both therapies attacks cancer cells through different pathways reduces drug resistance and can lower chemotherapy doses while improving outcomes.
COMBINATION THERAPY STRONG RESULTS
Research shows strong response rates with combination therapy reaching up to eighty percent compared to thirty percent with chemotherapy alone.
CANCER TYPES BENEFITING FROM COMBINATION THERAPY
Breast lung liver colorectal and blood cancers show improved response when chemotherapy is combined with targeted agents.
THE FUTURE OF COMBINATION CANCER CARE
New biomarkers and next generation therapies will continue to guide personalized combination treatments offering better results and improved quality of life.